Holen Sie sich die Stockscreener-App
85.99
1.52%
-1.33
Handel nachbörslich:
85.99
Schlusskurs vom Vortag:
$87.32
Offen:
$87.99
24-Stunden-Volumen:
2.19M
Relative Volume:
1.00
Marktkapitalisierung:
$17.04B
Einnahmen:
$7.83B
Nettoeinkommen (Verlust:
$825.20M
KGV:
20.94
EPS:
4.1067
Netto-Cashflow:
$1.05B
1W Leistung:
-0.93%
1M Leistung:
-5.27%
6M Leistung:
-11.85%
1J Leistung:
-23.62%
1-Tages-Spanne:
$85.43
$88.06
1-Wochen-Bereich:
$85.43
$89.00
52-Wochen-Spanne:
$85.33
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
85.99 | 17.31B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2026-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Market Leaders: What is the dividend yield of Zimmer Biomet Holdings IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
ZBH.SW Zimmer Biomet (SIX) spikes to CHF67.50 pre-market 28 Jan 2026: monitor liquidity - Meyka
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution - PR Newswire
Global Arthroscopy Devices Market is Expected to Expand at a Healthy Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.
What Analysts Think Is Reframing Zimmer Biomet (ZBH) Story For Investors - Yahoo Finance
TD Cowen assumes coverage on Zimmer Biomet stock with Buy rating - Investing.com Canada
Zimmer Biomet Holdings (ZBH)’s 2026 expectations remain cautious amid internal reset - MSN
Decliners Report: Is Zimmer Biomet Holdings Inc exposed to currency risksJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - baoquankhu1.vn
Support Test: Is FBNC stock overvalued or fairly priced2025 Year in Review & Smart Investment Allocation Insights - baoquankhu1.vn
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Sector Gamma AS - MarketBeat
Strs Ohio Cuts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ARGA Investment Management LP Acquires Shares of 154,539 Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
How Investors May Respond To Zimmer Biomet (ZBH) Cautious 2026 Outlook And Executive Departure - simplywall.st
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) - GlobeNewswire
Report: Zimmer Biomet planning layoffs - insideindianabusiness.com
The Truth About Zimmer Biomet Stock: Silent Boom Or Boring Boomer Play? - AD HOC NEWS
Zimmer Biomet launches new foot and ankle system - MassDevice
Bone Growth Stimulator Market Covering Prime Factors - openPR.com
Rakuten Investment Management Inc. Makes New $37.31 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (ZBH)’s 2026 Expectations Remain Cautious Amid Internal Reset - Insider Monkey
Q3 Rundown: Zimmer Biomet (NYSE:ZBH) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
Income Plays: Is CAPS currently under institutional pressureEarnings Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - Intellectia AI
Short Interest in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Rises By 33.0% - MarketBeat
Is It Time To Reassess Zimmer Biomet (ZBH) After Prolonged Share Price Weakness - Yahoo Finance
Zimmer Biomet (ZBH) Valuation Check After Cautious Guidance At J.P. Morgan Healthcare Conference - Sahm
Minneapolis Portfolio Management Group LLC Has $26.02 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet granted CE Mark for RibFix Advantage Fixation System - MSN
Zimmer Biomet (NYSE:ZBH) Upgraded to Buy at Wall Street Zen - MarketBeat
Zimmer Biomet (ZBH) Mixes Executive Exit With Big DTC Push Is Management Rewriting Its Playbook? - simplywall.st
Goldman Sachs Adjusts Price Target on Zimmer Biomet to $88 From $93, Maintains Sell Rating - marketscreener.com
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results - BioSpace
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - sharewise.com
What is the dividend yield of Zimmer Biomet Holdings IncQuarterly Trade Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Buyback Watch: What is the dividend yield of Zimmer Biomet Holdings Inc2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Zimmer Biomet’s Q3 2025 earnings: What to expect - MSN
Zimmer Biomet Announces Webcast and Conference Call of Fourth Qu - GuruFocus
Zimmer Biomet Announces Q4 2026 Earnings Call Date - Intellectia AI
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN
JPM26: Zimmer Biomet in midst of largest patient campaign in its history - Yahoo Finance
Zimmer Biomet (ZBH) Ensures Cautious Outlook for 2026 Transforma - GuruFocus
Zimmer Biomet (ZBH) Cautions Investors Ahead of Earnings Release - GuruFocus
Zimmer Biomet drops after cautious remarks on outlook - MSN
Zimmer Biomet down after cautious remarks on outlook (ZBH:NYSE) - Seeking Alpha
Setup Watch: Can Zimmer Biomet Holdings Inc stock outperform in 2025 bull marketEarnings Trend Report & AI Enhanced Trading Signals - moha.gov.vn
Zimmer Biomet’s Q3 2025 Earnings: What to Expect - Yahoo Finance
Daily CourierZimmer Biomet’s Q3 2025 Earnings: What to Expect - FinancialContent
Zimmer Biomet Holdings Inc (NYSE:ZBH) Screened as a 'Decent Value' Investment Opportunity - Chartmill
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):